Kenvue

Kenvue ROE

The Return on Equity (ROE) of Kenvue (KVUE) as of Nov 3, 2026 is 13.66 %. In the previous year, Return on Equity (ROE) was 10.65 % — a change of 28.17% (higher).

ROE

13.66 %

YoY

28.17%

Last updated:

In 2025, Kenvue's return on equity (ROE) was 13.66 %, a 28.17% increase from the 10.65 % ROE in the previous year.

The Kenvue ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2020
-4.79 USD
Jan 1, 2021
10.19 USD
Jan 1, 2022
10.34 USD
Jan 1, 2023
14.84 USD
Jan 1, 2024
10.65 USD
Jan 1, 2025
13.66 USD
The Kenvue ROE history
YEARROEYoY
13.66 %+28.17%
10.65 %-28.22%
14.84 %+43.61%
10.34 %+1.46%
10.19 %-312.73%
-4.79 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Kenvue Stock analysis

What does Kenvue do? Kenvue Inc. generates revenue through its three business segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment sells products like Tylenol for pain care, Zyrtec for allergies, and Nicorette for smoking cessation. The Skin Health and Beauty segment offers Neutrogena face and body care, Listerine for oral hygiene, and Aveeno for skin health. Essential Health includes Johnson’s baby care, Band-Aid for wound care, and oral care products. These brands target consumers globally across 165 countries, with distribution via 114 centers and 38 customer service hubs. Kenvue’s differentiated brand portfolio drives sales, with Tylenol, Neutrogena, and Listerine as key products. The Self Care segment focuses on cough, cold, and allergy remedies, while Skin Health and Beauty emphasizes face and body care. Essential Health covers oral care, baby care, and women’s health products. The company serves consumers directly through retail channels in all regions, leveraging its global distribution network. The company’s revenue streams come from selling its branded products in self-care, skin health, and essential health categories. Tylenol leads in pain care, Neutrogena dominates face and body care, and Johnson’s is prominent in baby care. Brands like Listerine and Aveeno cater to oral and skin health needs, while Band-Aid addresses wound care. Sales occur across 165 countries through 114 distribution centers and 38 customer service centers. Kenvue is one of the most popular companies on Eulerpool.

ROE Details

Decoding Kenvue's Return on Equity (ROE)

Kenvue's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Kenvue's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Kenvue's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Kenvue’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Kenvue stock

Return on Equity (ROE) of Kenvue is 13.66 % in 2025.

Return on Equity (ROE) of Kenvue changed from 10.65 % to 13.66 %, representing a 28.17% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Kenvue since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Kenvue with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Kenvue

All Key Metrics — Kenvue